Skip to main content
SpringerLink
Log in

Pharmacokinetic Evaluation of Herbal Remedies

Basic Introduction, Applicability, Current Status and Regulatory Needs

  • Leading Article
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. De Smet PAGM. Ritual enemas and snuffs in the Americas. Latin America Studies no.33, Centra de Estudios y Documentacíon Latinoamericanos. Dordrecht: Foris Publications, 1985

  2. De Smet PAGM, Rivier L. A general outlook on ethnopharmacology. J Ethnopharmacol 1989; 25: 127–38

    Article  PubMed  Google Scholar 

  3. Homma M, Oka K, Yamada T, et al. A strategy for discovering biologically active compounds with high probability in traditional Chinese herb remedies: an application of Saiboku-To in bronchial asthma. Anal Biochem 1992; 202: 179–87

    Article  PubMed  CAS  Google Scholar 

  4. Homma M, Oka K, Niitsuma T, et al. Pharmacokinetic evaluation of traditional Chinese herbal remedies. Lancet 1993; 341: 1595

    Article  PubMed  CAS  Google Scholar 

  5. Homma M, Oka K, Kobayashi H, et al. Liquid chromatographic determination of magnolol in urine collected from volunteers after a single dose of Saiboku-To, an oriental herbal medicine for bronchial asthma. J Pharm Pharmacol 1993; 45: 839–41

    Article  PubMed  CAS  Google Scholar 

  6. Homma M, Oka K, Kobayashi H, et al. Impact of free magnolol excretions in asthmatic patients who responded well to Saiboku-To, a Chinese herbal medicine. J Pharm Pharmacol 1993; 45: 844–6

    Article  PubMed  CAS  Google Scholar 

  7. Kruger PB, Albrecht CF, Liebenberg RW, et al. Studies on hypoxoside and rooperol analogues from Hypoxis rooperi and Hypoxis latifolia and their biotransformation in man by using high-performance liquid chromatography with in-line sorption enrichment and diode-array detection. J Chromatogr 1994; 662: 71–8

    CAS  Google Scholar 

  8. Albrecht CF, Theron EJ, Kruger PB. Morphological characterisation of the cell-growth inhibitory activity of rooperol and pharmacokinetic aspects of hypoxoside as an oral prodrug for cancer therapy. S Afr Med J 1995; 85: 853–60

    PubMed  CAS  Google Scholar 

  9. Albrecht CF, Kruger PB, Smit BJ, et al. The pharmacokinetic behaviour of hypoxoside taken orally by patients with lung cancer in a phase I trial. S Afr Med J 1995; 85: 861–5

    PubMed  CAS  Google Scholar 

  10. Smit BJ, Albrecht CF, Liebenberg RW, et al. A phase I trial of hypoxoside as an oral prodrug for cancer therapy — absence of toxicity. S Afr Med J 1995; 85: 865–70

    PubMed  CAS  Google Scholar 

  11. Ott J. Ayahuasca analogues: pangaean entheogens. Kennewick: Natural Products Co., 1994

  12. Gibaldi M, Prescott L. Handbook of clinical pharmacokinetics. Balgowlah: ADIS Health Science Press, 1983

  13. White NJ. Clinical pharmacokinetics of antimalarial drugs. Clin Pharmacokinet 1985; 10: 187–215

    Article  PubMed  CAS  Google Scholar 

  14. Paar WD, Schuhler H, Fimmers R, et al. Sparteine oxidation polymorphism: phenotyping by measurement of sparteine and its dehydrometabolites in plasma. Eur J Clin Pharmacol 1989; 36: 555–60

    Article  PubMed  CAS  Google Scholar 

  15. Alván G, Bechtel P, Iselius L, et al. Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations. Eur J Clin Pharmacol 1990; 39: 533–7

    Article  PubMed  Google Scholar 

  16. Eichelbaum M, Woolhouse NM. Inter-ethnic difference in sparteine oxidation among Ghanaians and Germans. Eur J Clin Pharmacol 1985; 28: 79–83

    Article  PubMed  CAS  Google Scholar 

  17. Arias TD, Jorge LF, Barrantes R, et al. The oxidative metabolism of sparteine in the Cuna Amerindians of Panama: absence of evidence for deficient metabolizers. Clin Pharmacol Ther 1988; 43: 456–65

    Article  PubMed  CAS  Google Scholar 

  18. Woolhouse NM, Eichelbaum M, Oates NS, et al. Dissociation of co-regulatory control of debrisoquin/phenformin and sparteine oxidation in Ghanaians. Clin Pharmacol Ther 1985; 37: 512–21

    Article  PubMed  CAS  Google Scholar 

  19. Rimchala P, Karbwang J, Sukontason K, et al. Pharmacokinetics of quinine in patients with chronic renal failure. Eur J Clin Pharmacol 1996; 49: 497–501

    Article  PubMed  CAS  Google Scholar 

  20. Karbwang J, Thanavibul A, Molunto P, et al. The pharmacokinetics of quinine in patients with acute hepatitis B. Br J Clin Pharmacol 1993; 35: 444–6

    Article  PubMed  CAS  Google Scholar 

  21. Auprayoon P, Sukontason K, Na-Bangchang K, et al. Pharmacokinetics of quinine in chronic hepatic failure. Br J Clin Pharmacol 1995; 40: 494–7

    Article  PubMed  CAS  Google Scholar 

  22. Kévorkian J-P, Michel C, Hofmann U, et al. Assessment of individual CYP2D6 activity in extensive metabolizers with renal failure: comparison of sparteine and dextromethorphan. Clin Pharmacol Ther 1996; 59: 583–92

    Article  PubMed  Google Scholar 

  23. Wanwimolruk S, Wong SM, Coville PF, et al. Cigarette smoking enhances the elimination of quinine. Br J Clin Pharmacol 1993; 36: 610–4

    Article  PubMed  CAS  Google Scholar 

  24. Wanwimolruk S, Wong S-M, Zhang H, et al. Metabolism of quinine in man: identification of a major metabolite and effects of smoking and rifampicin pretreatment. J Pharm Pharmacol 1995; 47: 957–63

    Article  PubMed  CAS  Google Scholar 

  25. Haag HB, Larson PS, Schwartz JJ. The effect of urinary pH on the elimination of quinine in man. J Pharmacol Exp Ther 1943; 79: 136

    CAS  Google Scholar 

  26. Wesley-Hadzija B. A note on the influence of diet in West Africa on urinary pH and excretion of amphetamine in man. J Pharm Pharmacol 1971; 23: 366–8

    Article  PubMed  CAS  Google Scholar 

  27. Pierpaoli PG. Drug therapy and diet. Drug Intell Clin Pharm 1972; 6: 89–99

    Google Scholar 

  28. Wanwimolruk S, Kang W, Coville PF, et al. Marked enhancement by rifampicin and lack of effect of isoniazid on the elimination of quinine in man. Br J Clin Pharmacol 1995; 40: 87–91

    Article  PubMed  CAS  Google Scholar 

  29. Wanwimolruk S, Sunbhanich M, Pongmarutai M, et al. Effects of cimetidine and ranitidine on the pharmacokinetics of quinine. Br J Clin Pharmacol 1996; 22: 346–50

    Article  Google Scholar 

  30. Eichelbaum M, Mineshita S, Ohnhaus EE, et al. The influence of enzyme induction on polymorphic sparteine oxidation. Br J Clin Pharmacol 1986; 22: 49–53

    Article  PubMed  CAS  Google Scholar 

  31. De Smet PAGM. Health risks of herbal remedies. Drug Saf 1995; 13: 81–93

    Article  PubMed  Google Scholar 

  32. Bisset NG, editor. Herbal drugs and phytopharmaceuticals: a handbook for practice on a scientific basis. Stuttgart: Medpharm Scientific Publishers, 1994

  33. Galloway JH, Farmer K, Weeks GR, et al. Potentially hazardous compound in a herbal slimming remedy. Lancet 1992; 340: 179

    Article  PubMed  CAS  Google Scholar 

  34. De Smet PAGM, D’Arcy PF. Drug interactions with herbal and other non-orthodox remedies. In: D’Arcy PF, McElnay JC, Wellington PJ, editors. Mechanisms of drug interactions. Berlin: Springer-Verlag, 1996: 327–52

    Chapter  Google Scholar 

  35. Germany leads in branded phytomedicines. OTC Bull 1996; 14 Jun: 15

  36. Schwabe U, Paffrath D, editors. Arzneiverordnungs report ’95: Aktuelle Daten, Kosten, Trends und Kommentare. Stuttgart: Gustav Fischer Verlag, 1995

  37. Grünwald J, Büttel K. The European phytotherapeutics market: figures, trends, analyses. Drugs Made in Germany 1996; 39: 6–11

    Google Scholar 

  38. Hänsel R, Keller K, Rimpler H, et al. Hagers Handbuch der Pharmazeutischen Praxis. 5th ed. Band 4: Drogen A-D. Berlin: Springer-Verlag, 1992

    Google Scholar 

  39. Hänsel R, Keller K, Rimpler H, et al. Hagers Handbuch der Pharmazeutischen Praxis. 5th ed. Band 5: Drogen E-O. Berlin: Springer-Verlag, 1993

    Google Scholar 

  40. Hänsel R, Keller K, Rimpler H, et al. Hagers Handbuch der Pharmazeutischen Praxis. 5th ed. Band 6: Drogen P-Z. Berlin: Springer-Verlag, 1994

    Google Scholar 

  41. Catalano S, Ferretti M, Marsili A, et al. New constituents of Prunus africana bark extract. J Nat Prod 1984; 47: 910

    Article  PubMed  CAS  Google Scholar 

  42. Ritschel WA, Kastner U, Hussain AS, et al. Pharmacokinetics and bioavailability of β-sitosterol in the beagle dog. Arzneimittel Forschung 1990; 40: 463–8

    PubMed  CAS  Google Scholar 

  43. Heinemann T, Axtmann G, Von Bergmann K. Comparison of intestinal absorption of cholesterol with different plant sterols in man. Eur J Clin Invest 1993; 23: 827–31

    Article  PubMed  CAS  Google Scholar 

  44. Terry JG, McGill BL, Crouse III JR. Evaluation of the use of β-sitostanol as a nonabsorbable marker for quantifying cholesterol absorption. J Lipid Res 1995; 36: 2267–71

    PubMed  CAS  Google Scholar 

  45. Nishioka Y, Kyotani S, Miyamura M, et al. Influence of time of administration of a Shosaiko-to extract granule on blood concentration of its active constituents. Chem Pharm Bull 1992; 40: 1335–7

    Article  PubMed  CAS  Google Scholar 

  46. Uchida E, Fukasawa I, Matsuzaki Y, et al. Pharmacokinetics and pharmacodynamics of TJ-9 after single administration in Japanese healthy male volunteers. Jpn Pharmacol Ther 1995; 23: 659–70

    CAS  Google Scholar 

  47. Frohne D. Untersuchungen zur Frage der harndesinfizierenden Wirkungen von Bärentraubenblatt-Extrakten. Planta Med 1970; 18: 1–25

    Article  PubMed  CAS  Google Scholar 

  48. Paper DH, Koehler J, Franz G. Bioavailability of drug preparations containing a leaf extract of Arctostaphylos uvaursi (Uvae ursi folium) [abstract]. Planta Med 1993; 59 Suppl.: A589

    Article  Google Scholar 

  49. Morazzoni P, Bombardelli E. Vaccinium myrtillus L. Fitoterapia 1996; 67: 3–29

    CAS  Google Scholar 

  50. Pullman-Mooar S, Laposata M, Lern D, et al. Alteration of the cellular fatty acid profile and the production of eicosanoids in human monocytes by gamma-linolenic acid. Arthritis Rheum 1990; 33: 1526–33

    Article  PubMed  CAS  Google Scholar 

  51. Gral N, Beani JC, Bonnot D, et al. Étude des taux plasmatiques de psoralènes après de céleri. Ann Dermatol Venereol 1993; 120: 599–603

    PubMed  CAS  Google Scholar 

  52. Tschiersch K, Hölzl J. Resorption und Ausscheidung von Apigenin, Apigeninin-7-glucosid und Herniarin nach peroraler Gabe eines extrakts von Matricaria recutita (L.) [syn. Chamomilla recutita (L.) Rauschen]. Pharmazie 1993; 48: 554–5

    PubMed  CAS  Google Scholar 

  53. Soulimani R, Younos C, Mortier F, et al. The role of stomachal digestion on the pharmacological activity of plant extracts, using as an example extracts of Harpagophytum procumbens. Can J Physiol Pharmacol 1994; 72: 1532–6

    Article  PubMed  CAS  Google Scholar 

  54. Van Doormaal JJ, Idema IG, Muskiet FAJ, et al. Effects of short-term high dose intake of evening primrose oil on plasma and cellular fatty acid compositions, α-tocopherol levels, and erythropoiesis in normal and type 1 (insulin-dependent) diabetic men. Diabetologia 1988; 31: 576–84

    Article  PubMed  Google Scholar 

  55. Abraham RD, Riemersma RA, Elton RA, et al. Effects of saf-flower oil and evening primrose oil in men with a low dihomo-gamma-linolenic level. Atherosclerosis 1990; 81: 199–208

    Article  PubMed  CAS  Google Scholar 

  56. Jandke J, Spiteller G. Unusual conjugates in biological products originating from consumption of onions and garlic. J Chromatogr 1987; 421: 1–8

    Article  PubMed  CAS  Google Scholar 

  57. Bartzatt R, Blum D, Nagel D. Isolation of garlic derived sulphur compounds from urine. Anal Lett 1992; 25: 1217–24

    Article  CAS  Google Scholar 

  58. De Rooij BM, Boogaard PJ, Rijksen DA, et al. Urinary excretion of N-acetyl-S-allyl-L-cysteine upon garlic consumption by human volunteers. Arch Toxicol 1996; 70: 635–9

    Article  PubMed  Google Scholar 

  59. Nieder M. Pharmakokinetik der ginkgo-flavonole im plasma. Münch Med Wochenschr 1991; 133 Suppl. 1: S61–S62

    Google Scholar 

  60. Fourtillan JB, Brisson AM, Girault J, et al. Propriétés pharmacocinétiques du Bilobalide et des Ginkgolides A et B chez le sujet sain après administrations intraveineuses et orales d’extrait de Ginkgo biloba (EGb 761). Thérapie 1995; 50: 137–44

    PubMed  CAS  Google Scholar 

  61. Cui JF, Garle M, Bjorkhem I, et al. Determination of aglycones of ginsenosides in ginseng preparations sold in Sweden and in urine samples from Swedish athletes consuming ginseng. Scand J Clin Lab Invest 1996; 56: 151–60

    Article  PubMed  CAS  Google Scholar 

  62. Grimaldi R, De Ponti F, D’Angelo L, et al. Pharmacokinetics of the total triterpenic fraction of Centella asiatica after single and multiple administrations to healthy volunteers: a new assay for asiatic acid. J Ethnopharmacol 1990; 28: 235–41

    Article  PubMed  CAS  Google Scholar 

  63. Kunz K, Schaffler K, Biber A, et al. Bioverfügbarkeit von beta-Aescin nach oraler Gabe zweier Aesculus-Extrakt enthaltender Darreichungsformen an gesunden Probanden. Pharmazie 1991; 46: 145

    PubMed  CAS  Google Scholar 

  64. Schrader E, Schwankl W, Sieder C, et al. Vergleichende Untersuchung zur Bioverfuegbarkeit von beta-Aescin nach oraler Einmalverabreichung zweier Rosskastaniensamenextrakt enthaltender, galenisch unterschiedlicher Darreichungsformen. Pharmazie 1995; 50: 623–7

    PubMed  CAS  Google Scholar 

  65. Veit M. Zur Pharmakokinetik pflanzlicher Phenole. Pharm Ztg 1996; 141(12): 52–3

    Google Scholar 

  66. Duffield AM, Jamieson DD, Lidgard RO, et al. Identification of some human urinary metabolites of the intoxicating beverage kava. J Chromatogr 1989; 475: 273–81

    Article  PubMed  CAS  Google Scholar 

  67. Maitai CK, Mugera GM. Excretion of the active principle of Catha edulis (miraa) in human urine. J Pharm Sci 1975; 64: 702–3

    Article  PubMed  CAS  Google Scholar 

  68. Kristiansson B, Abdul Ghani N, Eriksson M, et al. Use of khat in lactating women: a pilot study on breast-milk secretion. J Ethnopharmacol 1987; 21: 85–90

    Article  PubMed  CAS  Google Scholar 

  69. Widler P, Mathys K, Brenneisen R, et al. Pharmacodynamics and pharmacokinetics of khat: a controlled study. Clin Pharmacol Ther 1994; 55: 556–62

    Article  PubMed  CAS  Google Scholar 

  70. Itoh M, Asakawa N, Hashimoto Y, et al. Quantitative analysis of glycyrrhizin and glycyrrhetinic acid in plasma after administration of FM-100 by using gas chromatography-selected ion monitoring. Yakugaku Zasshi 1985; 105: 1150–4

    CAS  Google Scholar 

  71. De Groot G, Koops R, Hogendoorn EA, et al. Improvement of selectivity and sensitivity by column switching in the determination of glycyrrhizin and glycyrrhetic acid in human plasma by high-performance liquid chromatography. J Chromatogr 1988; 456: 71–81

    PubMed  Google Scholar 

  72. Yamamura Y, Kawakami J, Santa T, et al. Pharmacokinetic profile of glycyrrhizin in healthy volunteers by a new high-performance liquid Chromatographic method. J Pharm Sci 1992; 81: 1042–6

    Article  PubMed  CAS  Google Scholar 

  73. Abe K, Suzuki A, Katayama H, et al. Determination of 18β-glycyrrhetic acid in human plasma by high-performance liquid chromatography. J Chromatogr B 1994; 653: 112–5

    Article  CAS  Google Scholar 

  74. Raggi MA, Maffei F, Bugamelli F, et al. Bioavailability of glycyrrhizin and licorice extract in rat and human plasma as detected by a HPLC method. Pharmazie 1994; 49: 269–72

    PubMed  CAS  Google Scholar 

  75. Raggi MA, Bugamelli F, Nobile L, et al. HPLC determination of glycyrrhizin and glycyrrhetic acid in biological fluids, after licorice extract administration to humans and rats. Boll Chim Farm 1994; 133: 704–8

    PubMed  CAS  Google Scholar 

  76. Cantelli-Forti G, Maffei F, Hrelia P, et al. Interaction of licorice on glycyrrhizin pharmacokinetics. Environ Health Perspect 1994; 102 Suppl. 9: 65–8

    Article  Google Scholar 

  77. Schulz V, Löffler A, Gheorghiu T. Resorption von Blausäure aus Leinsamen. Leber Magen Darm 1983; 13: 10–4

    PubMed  CAS  Google Scholar 

  78. Rosling H. Cyanide exposure from linseed. Lancet 1993; 341: 177

    Article  PubMed  CAS  Google Scholar 

  79. Lampe JW, Martini MC, Kurzer MS, et al. Urinary lignan and isoflavonoid excretion in premenopausal women consuming flaxseed powder. Am J Clin Nutr 1994; 60: 122–8

    PubMed  CAS  Google Scholar 

  80. McManus RM, Jumpson J, Finegood DT, et al. A comparison of the effects of n-3 fatty acids from linseed oil and fish oil in well-controlled type II diabetes. Diabetes Care 1996; 19: 463–7

    Article  PubMed  CAS  Google Scholar 

  81. Barzaghi N, Crema F, Gatti G, et al.Pharmacokinetic studies on IdB 1016, a silybin-phosphatidylcholine complex, in healthy human subjects. Eur J Drug Metab Pharmacokin 1990; 15: 333–8

    Article  CAS  Google Scholar 

  82. Schandalik R, Gatti G, Perucca E. Pharmacokinetics of silybin in bile following administration of silipide and silymarin in cholecystectomy patients. Arzneimittel Forschung 1992; 42: 964–8

    PubMed  CAS  Google Scholar 

  83. Weyhenmeyer R, Mascher H, Birkmayer J. Study on dose-linearity of the pharmacokinetics of silibinin diastereomers using a new stereospecific assay. Int J Clin Pharmacol Ther Toxicol 1992; 30: 134–8

    PubMed  CAS  Google Scholar 

  84. Mascher H, Kikuta C, Weyhenmeyer R. Diastereomeric separation of free and conjugated silibinin in plasma by reversed phase HPLC after specific extraction. J Liq Chromatogr 1993; 16: 2777–89

    Article  CAS  Google Scholar 

  85. Schulz H-U, Schurer M, Krumbiegel G, et al. Untersuchungen zum Freisetzungsverhalten und zur Bioäquivalenz von Silymarin-präparaten. Arzneimittel Forschung 1995; 45: 61–4

    PubMed  CAS  Google Scholar 

  86. Rickling B, Hans B, Kramarczyk R, et al. Two high-performance liquid chromatographic assays for the determination of free and total silibinin diastereomers in plasma using column switching with electrochemical detection and reversed-phase chromatography with ultraviolet detection. J Chromatogr B Biomed Appl 1995; 670: 267–77

    Article  PubMed  CAS  Google Scholar 

  87. Zimmermann T, Seiberling M, Thomann P, et al. Untersuchungen zur relativen Bioverfügbarkeit und zur Pharmakokinetik von Myrtol standardisiert. Arzneimittel Forschung 1995; 45: 1198–201

    PubMed  CAS  Google Scholar 

  88. Somerville KW, Richmond CR, Bell GD. Delayed release peppermint oil capsules (Colpermin) for the spastic colon syndrome: a pharmacokinetic study. Br J Clin Pharmacol 1984; 18: 638–40

    Article  PubMed  CAS  Google Scholar 

  89. White DA, Thompson SP, Wilson CG, et al. A pharmacokinetic comparison of two delayed-release peppermint oil preparations, Colpermin and Mintec, for treatment of irritable bowel syndrome. Int J Pharm 1987; 40: 151–5

    Article  CAS  Google Scholar 

  90. Kaffenberger RM, Doyle MJ. Determination of menthol and menthol glucuronide in human urine by gas chromatography using an enzyme-sensitive internal standard and flame ionization detection. J Chromatogr 1990; 527: 59–66

    Article  PubMed  CAS  Google Scholar 

  91. De Bernardi Di Valserra M, Tripodi AS, Contos S, et al. Serenoa repens capsules: a bioequivalence study. Acta Toxicol Ther 1994; 15: 21–39

    Google Scholar 

  92. De Bernardi Di Valserra M, Tripodi AS. Biodisponibilità e farmacocinetica per via rettale nel volontario sano di una nuova formulazione di Serenoa repens. Arch Med Intern 1994; 46(2): 77–86

    Google Scholar 

  93. Faber P, Strenge-Hesse A. Relevance of rhein excretion into breast milk. Pharmacology 1988; 36 Suppl. 1: 212–20

    Article  Google Scholar 

  94. Krumbiegel G, Schulz HU. Rhein and aloe-emodin kinetics from senna laxatives in man. Pharmacology 1993; 47 Suppl. 1: 120–4

    Article  Google Scholar 

  95. Stock S, Hölzl J. Pharmacokinetic test of [14C]-labelled hypericin and pseudohypericin from Hypericumperforatumand serum kinetics of hypericin in man. Planta Med 1991; 57 Suppl. 2: A61–A62

    Article  Google Scholar 

  96. Weiser D. Pharmakokinetik von Hypericin nach oraler Einnahme des Johanniskraut-Extraktes LI 160. Nervenheilkunde 1991; 10: 318–9

    Google Scholar 

  97. Staffeidt B, Kerb R, Brockmöller J, et al. Pharmacokinetics of hypericin and pseudohypericin after oral intake of the Hypericum perforatum extract LI 160 in healthy volunteers. J Geriatr Psychiatry Neurol 1994; 7 Suppl. 1: S47–S53

    Article  Google Scholar 

  98. Wagner H, Jurcic K. In-vitro und in-vivo metabolismus von 14C-Didrovaltrat. Planta Med 1980; 38: 366–76

    Article  PubMed  CAS  Google Scholar 

  99. Dieckmann H. Untersuchungen zur pharmakokinetik, metabolismus und toxikologie von baldrinalen [dissertation]. Berlin: Freie Universität, 1988

    Google Scholar 

  100. Schütt H, Hölzl J. Hypericin: Nur eine unwirksame Leitsubstanz? Pharm Ztg 1996; 141: 3679–80

    Google Scholar 

  101. De Smet PAGM. Legislatory outlook on the safety of herbal remedies. In: De Smet PAGM, Hänsel R, Keller K, et al., editors. Adverse effects of herbal drugs. Vol. 2. Heidelberg: Springer-Verlag 1993: 1–90

    Chapter  Google Scholar 

  102. Tyler VE. Herbal remedies. J Pharm Technol 1995; 11: 214–20

    Google Scholar 

  103. De Smet PAGM. Should herbal medicine-like products be licensed as medicines. Special licensing seems the best way forward [editorial]. BMJ 1995; 310: 1023–4

    Article  PubMed  Google Scholar 

  104. Sears C. The easy way to sell drugs. New Scientist 1995; 148(no. 2002): 36–40

    Google Scholar 

  105. Guidelines on psychotropic drugs for the EC. Eur Neuropsychopharmacol 1994; 4: 61–77

    Article  Google Scholar 

  106. Timmers L. Herbal medicines used against epilepsy in developing countries. Utrecht: Science Shop for Drugs, Faculty of Pharmacy, State University, 1994

Download references

Author information

Authors and Affiliations

  1. Pharmaceutical Care Unit, Scientific Institute Dutch Pharmacists, Alexanderstraat 11, 2514 JL, The Hague, The Netherlands

    Peter A. G. M. De Smet

  2. Department of Pharmaceutical Pharmacology and Clinical Pharmacy, Groningen-Utrecht Institute for Drug Exploration (GUIDE), State University, Groningen, The Netherlands

    Jacobus R. B. J. Brouwers

Authors
  1. Peter A. G. M. De Smet
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jacobus R. B. J. Brouwers
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Smet, P.A.G.M., Brouwers, J.R.B.J. Pharmacokinetic Evaluation of Herbal Remedies. Clin-Pharmacokinet 32, 427–436 (1997). https://doi.org/10.2165/00003088-199732060-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-199732060-00001

Keywords

Search

Navigation